相关实验视频

Updated: Jul 19, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

对Mycobacterium tuberculosis的耐药性预测,使用参考图表

Michael B Hall^1,2, Leandro Lima¹, Lachlan J M Coin²

¹European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridgeshire, UK.

Microbial genomics

|August 8, 2023

概括

结核病耐药性预测通过使用参考图表的新工具DrPRG得到了改进. 这种方法提高了基因型药物敏感性测试 (DST) 的准确性和效率,有助于全球卫生工作.

科学领域:

基因组学就是基因组学.
微生物学微生物学
计算生物学计算生物学

背景情况:

结核病 (TB) 构成了全球卫生挑战,因抗菌素耐药性增加而加剧.
世界卫生组织 (WHO) 旨在实现对药物敏感性测试 (DST) 的普遍准入.
目前的现象型DST方法缓慢且基础设施密集,需要更快的替代方案.

研究的目的:

开发和评估DrPRG (用参考图进行药物耐药性预测),这是一种针对*Mycobacterium tuberculosis*的新型基因型DST工具.
评估DrPRG的表现与现有的工具,如Mykrobe和TBProfiler相比.
为了识别 *M.结核病* 的新型耐药性转移变异.

主要方法:

使用潘多拉细菌参考图法构建一个 *Mycobacterium tuberculosis* 耐药性参考图.
纳入具有不同药物敏感性概况的分离物的全球数据集.
使用44,709个Illumina和138个纳米孔样本对比DrPRG与Mykrobe和TBProfiler.

主要成果:

与现有的工具相比,DrPRG对某些药物的敏感性和特异性显著提高.
DrPRG 显示了较低的计算内存使用量和比 Mykrobe 和 TBProfiler 更快的运行时间.
发现了对抗性转移变异的新见解,包括基因删除 (*katG*, *pncA*).

结论:

DrPRG提供了一种更准确,更有效的方法,用于结核病的基因型DST.
该工具的性能和资源效率支持世卫组织实现可访问DST的目标.
对已识别的突变进行进一步的研究可能会改进结核病耐药性分类.

关键词:

结核病菌菌菌的结核病菌的结核病菌.一个基准的基准指标.药物耐药性的预测和预测基因组图表基因组图表参考图是指参考图的使用.软件软件软件软件软件

更多相关视频

Growth of Mycobacterium tuberculosis Biofilms

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...